ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1289

Classification of Osteoarthritis Phenotypes By Metabolomics Analysis

Weidong Zhang1, Sergei Likhodii2, Yuhua Zhang1, Erfan Aref-Eshghi1, Patricia E. Harper1, Edward Randell2, Roger Green1, Glynn Martin3, Andrew Furey3, Guang Sun4, Proton Rahman5,6 and Guangju Zhai1, 1Discipline of Genetics, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, 2Department of Laboratory Medicine, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, 3Department of Surgery, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, 4Discipline of Medicine, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, 5Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, 6Rheumatology, St. Claires Mercy Hospital, St. Johns, NF, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Biomarkers, metabolomics and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Osteoarthritis - Clinical Aspects: Epidemiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Osteoarthritis (OA) is a group of heterogeneous conditions consisting of different subgroups or phenotypes that continuously evolve, eventually leading to common clinical manifestations. Identifying OA subphenotypes and uncovering their different mechanisms of pathogenesis is of fundamental importance for the development of appropriate therapies and diagnostic tools. The aim of the study was to identify metabolic markers that can classify OA patients into subgroups.

Methods: A case-only study design was utilized in this study. Patients undergoing total hip/knee joint replacements due to primary OA were recruited and their synovial fluid samples were collected during their joint surgeries. Metabolic profiling was performed on the synovial fluid samples by the targeted metabolomics approach using the Biocrates AbsoluteIDQ p180 kit. Various analytic methods including principal component analysis (PCA), hierarchical clustering (HCL) method, and partial least squares discriminant analysis (PLS-DA) were utilized to identify metabolic markers for classifying subgroups of OA patients. Potential confounders such as age, sex, body mass index (BMI), and comorbidities were considered in the analysis.

Results: A total of 80 OA patients were included in the study. 38 were males and 42 were females with an average age of 65.2 ± 8.7 years. Two distinct patient groups, A and B, were clearly identified. Patients in group A had significant higher concentration on 39 acylcarnitines in their synovial fluids than the patients in group B. Patients in group B were further subdivided into five subgroups, i.e., B1-1, B1-2-1, B1-2-2, B2-1 and B2-2. The corresponding metabolites that contribute to the grouping were 14 amino acids, 24 glycerophospholipids, 12 acylcarnitines and 1 biogenic amine. The grouping was not associated with any known confounders including age, sex, BMI, and comorbidities. The possible biological processes involved in these clusters are carnitine, lipid, and collagen metabolism, respectively.

Conclusion: The study demonstrated that OA consists of metabolically distinct subgroups. Identification of these distinct subgroups will help to unravel the pathogenesis and develop targeted therapies for OA.


Disclosure:

W. Zhang,
None;

S. Likhodii,
None;

Y. Zhang,
None;

E. Aref-Eshghi,
None;

P. E. Harper,
None;

E. Randell,
None;

R. Green,
None;

G. Martin,
None;

A. Furey,
None;

G. Sun,
None;

P. Rahman,
None;

G. Zhai,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/classification-of-osteoarthritis-phenotypes-by-metabolomics-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology